Suppressed expression of PGC-1α (upregulate hepatic gluconeogenic gene expression) and gluconeogenic genes ameliorated hepatic insulin resistance and gluconeogenic activity by inhibiting the p38 MAPK/PGC-1α signal pathway. This evidence concerns the gene PPARGC1A and Insulin resistance.